Género y políticas sobre drogas en España: avances y limitaciones

Fernández Rodríugez, María Aránzazu; Dema Moreno, Sandra; Fontanil Gómez, Yolanda.
Rev. esp. drogodepend ; 45(1): 11-25, ene.-mar. 2020. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-192287

Documentos relacionados

  1. The legalization of cannabis derivatives in Spain: Hypothesis on a potential emerging market.
  2. [The debate over drug legalization].
  3. Navigating the nexus between British Columbia's public consumption and decriminalization policies of illegal drugs.
  4. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I. Temporary Scheduling Order.
  5. Illegal drugs laws: clearing a 50-year-old obstacle to research.
  6. [Discussing possible new regulations in german cannabis policy with special regard to the experiences in the Netherlands and Colorado].
  7. Strategies to Reduce Illicit Trade of Regular Nicotine Tobacco Products After Introduction of a Low-Nicotine Tobacco Product Standard.
  8. Schedules of Controlled Substances: Placement of Acetyl Fentanyl Into Schedule I. Final order.
  9. [The Herceptin® case : A case of falsification of medicinal products to a greater extent].
  10. Schedules of Controlled Substances: Temporary Placement of the Synthetic Cannabinoid MAB-CHMINACA Into Schedule I. Final order.